MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-16-2026
Psychemedics Corporation Total Liabilities 2011-2026 | PMD
Annual Total Liabilities Psychemedics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.19 M | 5.65 M | 7.96 M | 9.31 M | 11.5 M | 10.7 M | 6.23 M | 7.89 M | 9.42 M | 10.7 M | 11.2 M | 4.27 M | 2.9 M | 2.77 M | 2.09 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.5 M | 2.09 M | 7.05 M |
Quarterly Total Liabilities Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.39 M | 4.37 M | 4.87 M | 5.65 M | 6.68 M | 7.26 M | 7.74 M | 7.96 M | 8.76 M | 8.51 M | 8.51 M | 9.31 M | 9.61 M | 11.5 M | 11.6 M | 11.5 M | 11 M | 11.9 M | 9.4 M | 10.7 M | 8.76 M | 6.66 M | 7.04 M | 6.23 M | 8.47 M | 8.17 M | 8.56 M | 7.89 M | 8.22 M | 7.21 M | 9.24 M | 9.42 M | 12 M | 11.7 M | 11.4 M | 10.4 M | 11.1 M | 10.7 M | 10.5 M | 11.2 M | 10.6 M | 10.1 M | 5.59 M | 4.27 M | 2.99 M | 2.47 M | 2.34 M | 2.9 M | 2.73 M | 2.71 M | 1.82 M | 2.77 M | 2.77 M | 2.77 M | 2.77 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12 M | 1.82 M | 7.56 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
Celcuity
CELC
|
366 M | $ 88.57 | -4.22 % | $ 4.14 B | USA |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
4.11 M | $ 5.32 | -7.68 % | $ 7.08 M | USA |
 |
Castle Biosciences
CSTL
|
108 M | $ 21.2 | -1.85 % | $ 615 M | USA |
 |
Fulgent Genetics
FLGT
|
107 M | $ 19.02 | -2.46 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
12.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
84.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
2.11 B | $ 126.28 | -5.1 % | $ 15.8 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
11.5 M | $ 1.65 | -7.82 % | $ 7.3 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
110 M | $ 22.06 | -4.58 % | $ 1.18 B | USA |
 |
Illumina
ILMN
|
2.7 B | $ 161.86 | -3.69 % | $ 25.1 B | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
7.08 B | $ 148.91 | -2.55 % | $ 11.7 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
1.14 B | $ 101.99 | -0.81 % | $ 6.88 B | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.36 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
523 M | $ 10.82 | -4.33 % | $ 1.39 B | USA |
 |
Natera
NTRA
|
686 M | $ 215.8 | -2.84 % | $ 29.5 B | USA |
 |
Charles River Laboratories International
CRL
|
3.92 B | $ 182.78 | -1.63 % | $ 9.06 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
779 M | $ 1.4 | -13.85 % | $ 420 M | USA |
 |
Medpace Holdings
MEDP
|
1.52 B | $ 455.2 | -0.76 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
3.74 B | $ 1 154.6 | -2.19 % | $ 23.8 B |  Schweiz |
 |
Exact Sciences Corporation
EXAS
|
3.46 B | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
339 M | $ 4.63 | -1.39 % | $ 429 M | USA |
 |
National Research Corporation
NRC
|
121 M | $ 19.56 | -0.96 % | $ 438 M | USA |
 |
Personalis
PSNL
|
73 M | $ 10.54 | -12.93 % | $ 941 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
16 B | $ 26.17 | 0.67 % | $ 24.8 B |  Niderland |
 |
Senseonics Holdings
SENS
|
65.2 M | $ 6.63 | -5.49 % | $ 277 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.11 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
114 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.15 | 0.23 % | $ 4.94 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.76 B | $ 266.2 | 1.95 % | $ 22.1 B | USA |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 68.92 | -6.78 % | $ 4.12 B | USA |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 474.12 | -1.65 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.67 | -1.96 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
2.52 B | $ 367.04 | -2.49 % | $ 21.9 B | USA |
 |
Neogen Corporation
NEOG
|
1.37 B | $ 8.99 | -1.48 % | $ 1.95 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 201.12 | 2.53 % | $ 22.3 B | USA |